This is an image of some pharmaceuticals.Unfortunately, it has become very common that there are harmful side effects and serious health risks and damage from the use of prescription drugs and over the counter drugs that had required the FDA to issue warning and recalls. Some drugs may cause drug interaction, additional health problems and even death. If you or a family member have suffered injuries such as harmful side effects as a result of a defective or dangerous drug, you have the right to compensation from the manufacturer of that drug which caused your injuries. Mooney & Associates understand the pharmaceutical litigation laws and will diligently pursue compensation for you for your serious injuries.

When is a Recall Issued?

A recall is when a drug is removed from the market or a correction is made to the drug because it is either defective or potentially harmful. A company does this voluntarily if it discovers the problem or is required to do it because of concerns raised by the FDA. If you have a medicine that has been recalled, talk to your doctor about your risks and alternatives and return them to the place of purchase for refund.

Click the lists below show recent drug recalls:

2014

  • Our firm is now accepting cases involving a medical product called a Morcellator used to treat uterine fibroids. These devices were used during laparoscopic (minimally invasive) surgeries to treat uterine fibroids and during hysterectomies and myomectomies. Unfortunately it has been discovered that the morecellation products pose risk of spreading unsuspected cancerous tissue beyond the uterus. Most women will develop uterine fibroids at some point in their lives, although most cause no symptoms. In some cases, fibroids can cause symptoms, such as heavy or prolonged menstrual bleeding, pelvic pressure or pain, and/or frequent urination which require medical or surgical therapy. Many women choose to undergo laparoscopic hysterectomy or myomectomy and often these procedures are performed using a power morcellator. Based on FDA analysis and data currently available, if laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s long-term survival. If you or a loved one was treated with a morcellator and has been diagnosed with uterine sarcoma, leiomyosarcoma (LMS) or some other cancer that may have spread during a laparoscopic hysterectomy, a robotic hysterectomy or a laparoscopic myomectomy (uterine fibroid removal), contact our office immediately for a free consultation and evaluation.

2013

  • March 18, 2013 Clinical Specialties Issues Voluntary Nationwide Recall of Avastin Unit Dose Syringes due to Potential Serious Eye Infection
  • March 17, 2013 Medprep Consulting Inc. Announces Voluntary Nationwide Recall Of All Lots Of All Compounded Products Due To Potential Mold Contamination
  • March 16, 2013 Medprep Consulting Inc. Recalls All Lots Of Magnesium Sulfate 2gm In Dextrose 5 percent In Water, 50ml For Injecton Due To Mold Contamination
  • February 23, 2013 Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection
  • February 15, 2013 Reumofan Plus USA, LLC and Reumofan USA, LLC is Voluntarily Recalling all lots of Reumofan Plus Tablets Due to Undeclared Drug Ingredients
  • February 15, 2013 Gilead Recalls One Lot of Vistide® (CIDOFOVIR INJECTION) Due To Presence Of Particulate Matter
  • January 17, 2013 Advance Pharmaceutical Recalls one Lot (# 12G468) of Ferrous Sulfate Tablets, 325 mg, that may actually contain Meclizine HCl 25 mg tablets
  • January 10, 2013 Mobius Therapeutics, LLC Issues a Voluntary Recall of Mitosol® (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use

2012

  • December 20, 2012 Qualitest Pharmaceuticals Recalls Three Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Repackaged and Distributed by Mylan Institutional
  • December 18, 2012 Matrixx Initiatives Issues Nationwide Voluntary Recall of One Lot of Zicam®
  • December 14, 2012 Hospira Recalls Three Lots of Carboplatin Injection Due to Visible Particulate Matter
  • December 06, 2012 Qualitest Recalls 101 Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, Usp 10 Mg/500 Mg Due to the Potential for Oversized Tablets
  • November 28, 2012 Ranbaxy Recalls 41 Lots Of Atorvastatin Calcium Tablets 10 Mg, 20 Mg And 40 Mg Due to Potential Presence of Foreign Substance
  • November 27, 2012 Bracco Diagnostics Inc. Recalls Isovue® (iopamidol injection) Pre-Filled Power Injector Syringes due to Presence of Particulates
  • October 31, 2012 Ameridose Issues Recall of All Products
  • October 19, 2012 Energizer Holdings Inc., Recalls Several Banana Boat Sun Care Products
  • October 06, 2012 New England Compounding Center Product Recall Information
  • October 05, 2012 Hospira Recalls One Lot Of Lactated Ringer’s And 5-percent Dextrose Injection, Usp, 1000 Ml, Flexible Containers Due To Mold Contamination
  • September 20, 2012 Watson Issues Recalls Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg
  • September 10, 2012 Qualitest Recalls One Lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg
  • September 04, 2012 Sun Pharmaceutical Industries, Inc. Recalls One Lot of Nimodipine Capsules due to Crystallization of the Fill Material
  • August 15, 2012 Hospira Recalls One Lot of Hydromorphone Hydrochloride Injection 2 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject
  • August 14, 2012 Hospira Recalls Three Lots Of Propofol Due To Glass Vial Defect
  • July 25, 2012 DUKAL Corporation recalls selected lots of benzalkonium chloride swabs and antiseptic wipes
  • July 13, 2012 Hospira Recalls Certain Lots of Injectable Carboplatin, Cytarabine, Paclitaxel and Methotrexate
  • July 03, 2012 Bedford Laboratories Recalls Leucovorin Calcium Injection
  • June 28, 2012 Bedford Laboratories Issues Voluntary Hospital/User-Level Recall Of Vecuronium Bromide For Injection Preservative Free, Lot 2067134, Because Of Health Risk
  • June 05, 2012 Sandoz US Announces Precautionary Recall Of Oral Contraceptive Introvale®, Following Report Of Packaging Flaw
  • May 25, 2012 Franck’s Pharmacy: Compounded Prescription Recall
  • May 12, 2012 Hospira Recalls One Lot Of Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject, That May Contain More Than The Intended Fill Volume
  • May 02, 2012 Franck’s Compounding Lab Recalls Triamcinolone acetonide P.F. 80mg/ml
  • April 24, 2012 American Regent Recalls Epinephrine Injection, USP, 1:1000, 1mL Ampules Lot #1395 Due to Discoloration and Small Visible Particles
  • April 19, 2012 XROCK INDUSTRIES, LLC Recalls X-ROCK, a Product Marketed as a Dietary Supplement To Support Male Sexual Performance, Due to Unlisted, Potentially Hazardous Ingredient
  • April 17, 2012 Hospira Recalls One Lot of Morphine Sulfate Injection, USP 4 MG/ML, (C-II) 1 ML Fill in 2.5 ML Carpuject, That May Contain More Than The Intended Fill Volume
  • March 31, 2012 Franck’s Lab Recalls One Lot of triamcinolone acetonide P.F. 80mg/ml
  • April 02, 2012 American Regent Recalls Cyanocobalamin Injection, USP, 100 mcg/mL, 1ml Vial Lot #s 1662, 1679, 1683
  • March 09, 2012 Recall of Brilliant Blue G
  • February 16, 2012 Bedford Laboratories™ Issues Nationwide Voluntary Recall of Cytarabine for Injection, USP, 1 Gram per Vial
  • February 24, 2012 Regeneca, Inc. Issues a Voluntary Nationwide Recall of All Lots of Single Capsule RegenErect Because of Potential Health Risks
  • February 24, 2012 Glenmark Generics Inc. Recalls Seven Lots of Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg (Generic) Due to Possibility of Out of Sequence Tablets
  • February 22, 2012 American Regent Initiates Nationwide Voluntary Recall Of Phenylephrine HCl Injection, USP, 1% 5 mL Vial, Lot# 0693 Due To Visible Particles
  • February 17, 2012 McNeil Consumer Healthcare Announces Voluntary Nationwide Recall of Infants’ TYLENOL Oral Suspension, 1 oz. Grape Due to Dosing System Complaints
  • February 16, 2012 Bedford Laboratories Issues Nationwide Voluntary Recall of Cytarabine for Injection, USP, 1 Gram per Vial
  • February 10, 2012 Regeneca, Inc. Issues A Voluntary Nationwide Recall Of A Specific Lot Of RegenArouse Because Of Potential Health Risks
  • February 09, 2012 Wholistic Herbs, Inc. Recalls “Koff & Kold” and “Kold Sore” Because Of Possible Health Risk
  • February 06, 2012 North American Rescue, LLC Announces A Follow-Up to the Recall of Crickit Convenience Kits Related to Nationwide Recall of Triad Povidone Iodine Prep Pads
  • February 02, 2012 Bedford Laboratories Issues A Voluntary Nationwide Patient Level Recall Of Acetylcysteine Solution, USP, LOT 1877093
  • January 31, 2012 Pfizer Recalls Lo/Ovral-28 and Norgestrel/Ethinyl Estradiol Tablets Due to Possibility of Inexact Tablet Counts or Out of Sequence Tablets
  • January 27, 2012 One Lot of Aveeno Baby Calming Comfort Lotion Recalled
  • January 27, 2012 Cephalon, Inc. recalls Treanda® (bendamustine HCL) for Injection 25mg/Vial Due to Particulate Matter
  • January 19, 2012 Perfect Image Solutions, LLC Issues Voluntary Recall of Unapproved Product Due to Potential Health Risk
  • January 10, 2012 Bedford Laboratories Issues Guidance On 2011 Voluntary Recall Of Polymyxin B For Injection USP And Vecuronium Bromide For Injection Related To Glass Particles
  • January 08, 2012 Novartis Consumer Health Inc. Recalls Certain Over-The-Counter Products Due to Potential Presence Of Foreign Tablets Or Chipped Or Broken Tablets Or Gelcaps

2011

  • December 21, 2011 McNeil Recall of Motrin IB Tablets and Caplets
  • December 02, 2011 Eagle Pharmaceuticals, Inc. Recalls 4 Lots of Argatroban Injection 50 mg/50 mL (1 mg/mL) Due to a Potential for Visible Particulates
  • October 19, 2011 Insight Pharmaceuticals Recalls “Nostrilla Nasal Decongestant” Due To Bacterial Contamination
  • October 03, 2011 Superior Metabolic Technologies Inc Recalls Uprizing 2.0 Because the Product Contains Superdrol, Which is a Synthetic Steroid, Making it an Unapproved New Drug
  • September 15, 2011 Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives
  • August 24, 2011 H and P Industries, Inc. Recalls All Lots of Povidone Iodine Swabsticks, Povidone Iodine Prep Solutions, Povidone Iodine Scrub Solutions, and Povidone Iodine Prep Gel
  • August 02, 2011 American Regent, Inc. Initiates Voluntary Recall of Seventeen Lots of Vasopressin Injection, USP, Multiple Dose Vials Due to Sub-Potency
  • July 18, 2011 American Regent Initiates Voluntary Nationwide Recall of Calcium Gluconate Injection, USP, 10%, 100 mL Pharmacy Bulk Package Due to Particulates
  • June 28, 2011 McNeil Consumer Healthcare Announces Voluntary Recall Of One Product Lot Of TYLENOL ® Extra Strength Caplets 225 Count Distributed In The U.S.
  • June 24, 2011 Qualitest Pharmaceuticals Recalls Four Lots of Butalbital, Acetaminophen, and Caffeine Tablets, USP 50mg/325mg/40mg and Four Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5mg/500mg
  • June 24, 2011 Endo Pharmaceuticals Recalls Two Lots of Endocet (Oxycodone/Acetaminophen, USP) Tablets, 10 MG / 325 MG
  • June 22, 2011 Nature Relief is Conducting a Voluntary Recall of Nature Relief Instant Wart and Mole Remover
  • June 17, 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
  • June 15, 2011 American Regent Recalls Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial Due to Particulates
  • June 06, 2011 American Regent Recalls Methyldopate HCL Injection, USP 5 mL Single Dose Vial Due to Glass Particulates
  • June 01, 2011 Aidapak Services, LLC Recalls ALL Repackaged Pharmaceuticals by Aidapak Services, LLC Due to Potential Cross Contamination with Beta Lactam Products
  • May 19, 2011 American Regent Initiates Nationwide Voluntary Recall of Sterile Water for Injection, USP 50 mL Single Dose Vial Due to Particulate Matter
  • May 05, 2011 American Regent Recalls Caffeine and Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial
  • May 02, 2011 Bristol-Myers Squibb Recalls Coumadin (Warfarin Sodium) Crystalline 5 mg Tablets, Lot Number 9H49374A
  • April 26, 2011 American Regent Initiates Voluntary Nationwide Recall of Ammonium Molybdate Injection, USP (Molybdenum 250mcg/10 mL) 10 mL Single Dose Vial
  • April 14, 2011 Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX®
  • March 29, 2011 CDC And ADPH Investigate Outbreak At Alabama Hospitals; Products Recalled
  • March 26, 2011 Greenstone Recalls Citalopram and Finasteride Due to Possible Mislabeling
  • March 25, 2011 APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection
  • March 16, 2011 American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials
  • March 15, 2011 H and P Industries, Inc. Recall of All Lots of Povidine Iodine Prep Pads
  • March 15, 2011 American Regent Recalls Bacteriostatic Sodium Chloride Injection, USP, 0.9% 30 mL Multiple Dose Vials
  • March 05, 2011 OTC DRUG Nationwide Recall–Important information for patients about IV PREP Antiseptic Wipes
  • February 18, 2011 Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall. Affected Products Include Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantoven® and Oxybutynin
  • February 16, 2011 Upsher-Smith Laboratories Recalls Jantoven® Warfarin Sodium Tablets, USP, 3mg, Due To Mislabeled Bottles
  • February 05, 2011 Qualitest Pharmaceuticals Recalls Hydrocodone Bitartrate and Acetaminophen Tablets and Phenobarbital Tablets
  • February 04, 2011 Watson Announces Important Action Related to Nationwide Recall of Triad Alcohol Prep Products Included in Products
  • February 03, 2011 American Regent Recalls Potassium Phosphates Injection, USP 15 mM/5 mL Phosphorus; 22 mEq/5 mL Potassium 5 mL Single Dose Vial, Lot# 0048
  • January 26, 2011 Pfizer Inc. And Progenics Alert Physicians And Patients To Information Related To Triad Group Alcohol Prep Products Included In U.S. RELISTOR Kit Packaging
  • January 24, 2011 Important information for ARIXTRA® Starter Kit patients regarding Triad Group’s alcohol prep products
  • January 14, 2011 McNeil Consumer Healthcare Initiates Voluntary Recall Of Certain Over-The-Counter (OTC) Products
  • January 13, 2011 Genentech Informs Customers Of Important Information About Triad Groups
  • January 10, 2011 Important Information for Extavia® (interferon beta 1-b) Patients Regarding Triad Group’s Alcohol Prep Products
  • January 20, 2011 Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group’s Alcohol Prep Products
  • January 06, 2011 Teva Pharmaceuticals, U.S.A issues a voluntary nationwide recall of Metronidazole Tablets USP, 250mg Due to Low Weight Tablets
  • January 05, 2011 Triad Group Issues a Voluntary Nationwide Recall of All Lots of Alcohol Prep Pads, Alcohol Swabs, and Alcohol Swabsticks Due to Potential Microbial Contamination
  • October 03, 2011 Superior Metabolic Technologies Inc Recalls Uprizing 2.0 Because the Product Contains Superdrol, Which is a Synthetic Steroid, Making it an Unapproved New Drug

2010

  • December 30, 2010 The Ritedose Corporation Announces the Voluntary Nationwide Recall of 0.083% Albuterol Sulfate Inhalation Solution, 3 mL Due to Mislabeled Unit Dose Vials
  • December 30, 2010 Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials
  • December 23, 2010 American Regent Initiates Nationwide Voluntary Recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%, 50mL Single Dose Vials Due to Particulate Matter
  • December 22, 2010 Pfizer To Recall One Lot Of Lipitor In The U.S.
  • December 20, 2010 American Regent Initiates Voluntary Recall of Dexamethasone Sodium Phosphate Injection, USP 4 mg/mL, 30 mL Multiple Dose Vial
  • December 09, 2010 Reese Pharmaceutical Company Announces the Voluntary Nationwide Recall of Certain Over-The-Counter Cold Relief Products that are Mislabeled.
  • December 09, 2010 McNeil Consumer Healthcare Announces Voluntary Recall Of All Lots Of Rolaids® Extra Strength Softchews, Roldaids® Extra Strength Plus Gas Softchews, And Roldaids® Multi-Symptom Plus Anti-Gas Softchews Sold In The United States
  • November 29, 2010 Recall of Mylanta and Alternagel Liquid Products
  • November 24, 2010 Recall of Tylenol Cold Liquid Products
  • November 15, 2010 Recall of Children’s BENADRYL® Allergy FASTMELT® Tablets and Junior Strength MOTRIN® Caplets
  • November 15, 2010 Recall of ROLAIDS® Extra Strength Softchews
  • November 04, 2010 Actavis Encourages Consumers to Return Fentanyl Transdermal System 25 mcg/h
  • October 27, 2010 Sandoz initiates voluntary recall in the US of all 50mg/2mL and 250mg/10mL vials of Methotrexate Injection, USP due to the presence of glass particulates
  • October 23, 2010 WoStandard Homeopathic Company Voluntarily Recalls Hyland’s Teething Tablets
  • October 21, 2010 Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/h
  • October 18, 2010 McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in The United States and Puerto Rico
  • October 09, 2010 Pfizer Recalls Lipitor (40mg only)
  • September 24, 2010 Amgen Initiates Voluntary Nationwide Recall Of Certain Lots Of Epogen® And Procrit® (Epoetin Alfa)
  • July 30, 2010 Lundbeck Inc. Announces the Voluntary Nationwide Recall of Two Lots of NeoProfen® (ibuprofen lysine) Injection
  • July 12, 2010 Bristol-Myers Squibb Initiates a Nationwide Voluntary Recall of Coumadin (R) 1 mg Tablet Blister Packs
  • July 08, 2010 McNeil Consumer Healthcare Announces Voluntary Recall of Certain Over-The-Counter (OTC) Products
  • June 24, 2010 P&G Voluntarily Recalls 4 Hour Decongestant Nasal Spray in the United States
  • June 15, 2010 Mcneil Consumer Healthcare Recalls Four Product Lots of Benadryl® Allergy Ultratab™ Tablets, 100 Count, and One Product Lot of Extra Strength Tylenol® Rapid Release Gels, 50 Count
  • June 03, 2010 West-Ward Pharmaceuticals Recalls Ondansetron in 5% Dextrose Injection And Metronidazole Injection, USP Bags Due To Possible Health Risk
  • June 03, 2010 Pfizer Initiates a Nationwide Voluntary Recall of All Lots of Metronidazole Injection, Ciprofloxacin Injection, and Ondansetron Injection Bags Made by Claris Lifesciences Due to Non-Sterility
  • June 02, 2010 Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of All Lots of Ondansetron in 5% Dextrose Injection, 32 mg/50 mL Manufactured by Claris Lifesciences
  • June 01, 2010 Claris Lifesciences initiates a nationwide voluntary recall of all lots of Ciprofloxacin Inj. USP 200 mg / 100 mL, Ciprofloxacin Inj. USP 400 mg / 200 mL, Metronidazole Inj. USP 500 mg/100 ml and Ondansetron Inj., 32 mg / 50 mL.
  • May 28, 2010 Blacksmith Brands Announces Nationwide Voluntary Recall Of Four PediaCare Children’s Products
  • May 27, 2010 Hospira Announces an Expansion of a Nationwide Voluntary Recall of Certain Lots of Liposyn™ and Propofol That May Contain Particulate Matter
  • May 17, 2010 Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of All Lots of Metronidazole Injection, USP 500 mg/100 mL
  • May 17, 2010 Voluntary Recall of HYLENEX Initiated
  • April 30, 2010 McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Infants’ and Children’s Products
  • April 02, 2010 US Oftalmi Announces Voluntary Recall of the Camolyn Eye Drops Product Line, and Fisiolin Nasal Drops. Includes All Lots of 15mL Bottles.
  • March 17, 2010 The Medicines Company Expands a Nationwide Recall for Certain Lots of Cleviprex® That May Contain Particulate Matter
  • January 15, 2010 McNeil Consumer Healthcare Announces Voluntary Recall of Certain Over-The-Counter (OTC) Products in the Americas, UAE, and Fiji

Class 1 drugs have the highest probability that their use or exposure may cause serious adverse health consequences or death. If you or family member has been injured by exposure to any of these drugs or other prescription drugs or over the counter drugs, please contact Mooney & Associates to get the compensation you deserve.